MENU
NMRA
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Neumora Therapeutics (NMRA) Ownership - Who owns Neumora Therapeutics?
Profile
Industry
N/A
Address
490 Arsenal Way
Phone
+1 857 760-0900
Employees
124
Web
https://www.neumoratx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.12B
P/E Ratio
N/A
Total Cash
371.64M
Projected Growth
N/A
Total Debt
3.61M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.32
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NMRA
Capitalization
2.12B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
372M
Total Cash/Share
2.32
Total Debt
3.61M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
381M
P/B Ratio
5.55
Cash Flow
N/A
Earnings
-1.72
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
16K
Current Ratio
17.22
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-294.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-71.73
Shares Held By Institutions
766M
Shares Outstanding - Current
160M
Total Liabilities
23.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-0.528
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
490 Arsenal Way
Phone
+1 857 760-0900
Employees
124
Web
https://www.neumoratx.com